Skip to Main Content

Paper Details

Refractory antiphospholipid antibody syndrome-induced thrombocytopaenia successfully treated with belimumab.
Lupus
2
2022
Author NameAffiliation
Shinsuke Yasuda92190Tokyo Medical and Dental University (TMDU)
  • 1 - 1

Datasets

Release 1.2